Published in Eur J Surg Oncol on April 01, 2003
Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer (2011) 1.49
Treatment of malignant pheochromocytoma. Horm Metab Res (2009) 1.25
Paraganglioma: carotid body tumor. Head Neck Pathol (2009) 1.21
Malignant paraganglioma arising from the kidney. Int J Clin Oncol (2007) 0.90
Paraganglioma of the greater omentum: Case report and review of the literature. World J Surg Oncol (2007) 0.88
Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2). Proc Natl Acad Sci U S A (2008) 0.87
Advances in biochemical screening for phaeochromocytoma using biogenic amines. Clin Biochem Rev (2009) 0.87
Malignant pheochromocytomas and paragangliomas: a diagnostic challenge. Langenbecks Arch Surg (2011) 0.83
Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation. Endocr Relat Cancer (2013) 0.83
[Retroperitoneal non-secreting paraganglioma: a rare cause of high intestinal occlusion]. Pan Afr Med J (2014) 0.81
Successful outcome after resection of liver metastasis arising from an extraadrenal retroperitoneal paraganglioma that appeared 9 years after surgical excision of the primary lesion. Int J Clin Oncol (2009) 0.80
External beam radiation therapy in treatment of malignant pheochromocytoma and paraganglioma. Front Oncol (2014) 0.79
Nonfunctioning symptomatic paraganglioma: Is there an optimal follow-up for patients with extra-adrenal benign paragangliomas. J Surg Case Rep (2014) 0.78
High-throughput screening for growth inhibitors using a yeast model of familial paraganglioma. PLoS One (2013) 0.78
Current perioperative management of pheochromocytomas. Indian J Urol (2017) 0.75
Recurrent malignant pheochromocytoma with unusual omental metastasis: (68)Ga-DOTANOC PET/CT and (131)I-MIBG SPECT/CT scintigraphy findings. Indian J Nucl Med (2014) 0.75
Breast Metastasis Detected on Ga-68 DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Malignant Pheochromocytoma. World J Nucl Med (2015) 0.75
An unusual localization of retroperitoneal paraganglioma: a case report. Pan Afr Med J (2015) 0.75
Apogossypolone (ApoG2) induces ROS-dependent apoptosis and reduces invasiveness of PC12 cells in vitro and in vivo. Am J Transl Res (2017) 0.75
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07
Drug-induced changes in the release of ( 3 H)-noradrenaline from field stimulated rat iris. Br J Pharmacol (1971) 2.27
Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23
Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A (1982) 1.95
Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J Neurosurg (1985) 1.75
Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab (1998) 1.58
Paravertebral block during cholecystectomy: effects on circulatory and hormonal responses. Br J Anaesth (1988) 1.54
Drug-induced changes in the release of 3 H-monoamines from field stimulated rat brain slices. Acta Physiol Scand Suppl (1971) 1.51
Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer (2002) 1.51
Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta Physiol Scand (1967) 1.49
A sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection. Life Sci (1978) 1.45
Pheochromocytoma: current status and changing trends. Surgery (1982) 1.44
Uptake of catecholamines and penetration of trypan blue after blood-brain barrier lesions. A histochemical study. Z Zellforsch Mikrosk Anat (1966) 1.40
Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab (1996) 1.40
Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci Lett (1986) 1.38
KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma. Mod Pathol (2003) 1.36
A quantitative study on the nigro-neostriatal dopamine neuron system in the rat. Acta Physiol Scand (1967) 1.35
ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors. Eur J Pharmacol (1972) 1.31
Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma. Proc Natl Acad Sci U S A (1979) 1.26
Uptake and accumulation of 3H-noradrenaline in adrenergic nerves of rat iris. Effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition. Eur J Pharmacol (1969) 1.24
Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. Cancer Res (1996) 1.23
Effects of desipramine, phentolamine and phenoxybenzamine on the release of noradrenaline from isolated tissues. J Pharm Pharmacol (1970) 1.21
Pharmacokinetics and biological effects of nortriptyline in man. Acta Pharmacol Toxicol (Copenh) (1971) 1.21
Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology. Am J Pathol (2000) 1.21
Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. Endocr Relat Cancer (2007) 1.20
Studies on some systems of adrenergic synaptic terminals in the abdominal ganglia of the cat. Acta Physiol Scand (1965) 1.17
Constipation a commonly unrecognized cause of enuresis. Am J Dis Child (1986) 1.14
Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). J Med Genet (2004) 1.09
Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer (2006) 1.08
Extraneuronal binding of catecholamines and 3,4-dihydroxyphenylalanine (dopa) in salivary glands. Acta Physiol Scand (1967) 1.07
Localization of catecholamine uptake in rat brain slices. Acta Pharmacol Toxicol (Copenh) (1965) 1.07
Regulation of (3H)5-hydroxytryptamine release from rat brain slices. J Pharm Pharmacol (1974) 1.06
Reserpine-resistant uptake of catecholamines in isolated tissues of the rat. A histochemical study. Acta Physiol Scand Suppl (1967) 1.06
Quantitative in vitro studies on noradrenaline uptake and its inhibition by amphetamine, desipramine and chlorpromazine. Acta Physiol Scand (1968) 1.04
Adrenalectomy: anterior or posterior approach? Am J Surg (1982) 1.03
Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. J Clin Endocrinol Metab (1998) 1.02
ABC transporters coordinately expressed during lignification of Arabidopsis stems include a set of ABCBs associated with auxin transport. J Exp Bot (2011) 1.02
Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease. Eur J Pharmacol (1971) 1.02
Effect of some antiparkinsonian drugs on catecholamine neurons. J Pharm Pharmacol (1970) 1.00
Noradrenaline uptake and fluorescence histochemistry in bovine splenic nerves. Acta Physiol Scand (1971) 1.00
Alternative genetic pathways in parathyroid tumorigenesis. J Clin Endocrinol Metab (1999) 1.00
Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas. Surgery (1998) 0.99
Demonstration of catecholamines and 5-hydroxytryptamine in the human carotid body. J Pharmacol Exp Ther (1966) 0.99
Adrenergic synaptic terminals in autonomic ganglia. Acta Physiol Scand (1965) 0.97
Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s. Hum Mol Genet (1994) 0.94
Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma. Genes Chromosomes Cancer (2001) 0.94
Endothelin-1-like immunoreactivity is expressed in human reactive astrocytes. Neuroreport (1993) 0.94
Effect of ergot drugs on central 5-hydroxytryptamine neurons: evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulation. Eur J Pharmacol (1975) 0.94
Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas. Endocr Relat Cancer (2008) 0.93
D-[U-11C]glucose uptake and metabolism in the brain of insulin-dependent diabetic subjects. Am J Physiol (1990) 0.93
Distribution of noradrenaline nerve terminals in cortical areas of the rat. Brain Res (1968) 0.93
Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors. Hum Genet (1996) 0.92
Combined fluorescence histochemistry and 3H-noradrenaline measurements of adrenergic nerves. Histochemie (1968) 0.92
Uptake and release of alpha-methyl-noradrenaline in vitro after reserpine pretreatment. A histochemical study. Acta Physiol Scand (1968) 0.92
Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial. Arch Neurol (1991) 0.91
Surgical treatment of primary aldosteronism. Ann Chir Gynaecol (1983) 0.90
Influence of alpha- and beta-adrenoceptors on the release of noradrenaline from field stimulated atria and cerebral cortex slices. J Pharm Pharmacol (1974) 0.88
Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16. J Clin Endocrinol Metab (1999) 0.88
Catecholamines in brown fat. Nature (1967) 0.88
Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids. Am J Pathol (2001) 0.88
Neuropeptide Y and sympathetic vascular control in man. Regul Pept (1985) 0.87
Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor. Eur J Pharmacol (1970) 0.87
Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2). Proc Natl Acad Sci U S A (2008) 0.87
Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. Surgery (1992) 0.87
High- and low-dose fentanyl anaesthesia: hormonal and metabolic responses during cholecystectomy. Br J Anaesth (1988) 0.87
Lymphocytic hypophysitis: report of two biopsy-proven cases and one suspected case with pituitary autoantibodies. J Endocrinol Invest (2007) 0.86
Intraductal serrated adenoma of the pancreas. A case report. Anticancer Res (2005) 0.86
Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study. Thyroid (1998) 0.86
Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumors and plasma of pheochromocytoma patients. Regul Pept (1986) 0.86
Chromosomal alterations in human pancreatic endocrine tumors. Genes Chromosomes Cancer (2000) 0.86
Astrocytes in Alzheimer's disease express immunoreactivity to the vaso-constrictor endothelin-1. J Neurol Sci (1994) 0.86
Allelotyping of follicular thyroid tumors. Hum Genet (1995) 0.86
Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management. World J Surg (2000) 0.86
In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17. World J Surg (2001) 0.85
On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxytryptamine neurons, and their relation to the anorectic activity of fenfluramine. Postgrad Med J (1975) 0.85
Impact of screening on prognosis in the multiple endocrine neoplasia type 2 syndromes: natural history and treatment results in 105 patients. Henry Ford Hosp Med J (1984) 0.85
Suckling in lactating women stimulates the secretion of insulin and prolactin without concomitant effects on gastrin, growth hormone, calcitonin, vasopressin or catecholamines. Early Hum Dev (1984) 0.85
Plasma catecholamines during surgical stress: differences between neurolept and enflurane anaesthesia. Acta Anaesthesiol Scand (1983) 0.85
Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma. Melanoma Res (1995) 0.84
Evidence for co-transmitter role of neuropeptide Y in the pig spleen. Br J Pharmacol (1989) 0.84
Cellular localization of peptides in neural structures. Proc R Soc Lond B Biol Sci (1980) 0.84
The influence of abdominal surgical trauma on the exchange of blood-borne amino acids in the human leg. Clin Nutr (1986) 0.84
Long term experience after subtotal adrenalectomy for multiple endocrine neoplasia type IIa. Eur J Surg (1999) 0.84
The role of adrenal scintigraphy in the preoperative management of primary aldosteronism. Scand J Surg (2008) 0.83
Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition. J Neurochem (1971) 0.83
Alterations of p53 and expression of WAF1/p21 in human thyroid tumors. Thyroid (1996) 0.83
Insulin-like growth factor II in human fetal pancreas and its co-localization with the major islet hormones: comparison with adult pancreas. J Endocrinol (2000) 0.83
The role of plasma protein binding in the inhibitory effect of nortriptyline on the neuronal uptake of norepinephrine. Clin Pharmacol Ther (1970) 0.83
Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine-resistant uptake mechanism of central and peripheral monoamine neurones in vivo and in vitro. Br J Pharmacol (1969) 0.83
Counterregulation of insulin-induced hypoglycaemia in primary hypothyroidism. Acta Endocrinol (Copenh) (1986) 0.83
Preserved beta-cell density in the endocrine pancreas of young, spontaneously diabetic Goto-Kakizaki (GK) rats. Pancreas (1995) 0.83
Operation for primary hyperparathyroidism: the new versus the old order. A randomised controlled trial of preoperative localisation. Scand J Surg (2007) 0.82
Plasma catecholamine and free fatty acid levels during infusion of lipid emulsion in critically ill patients. Crit Care Med (1984) 0.82
Primary aldosteronism. Br J Surg (1992) 0.82
Substance P-like immunoreactive neurons in the nervous system of Drosophila. Brain Res (1990) 0.82
Prognostic value of nuclear DNA content in follicular thyroid tumours. Acta Chir Scand (1986) 0.82
Release of norepinephrine from isolated rat iris by field stimulation. J Pharmacol Exp Ther (1970) 0.82
Impaired counter regulation of hypoglycemia in a group of insulin-dependent diabetics with recurrent episodes of severe hypoglycemia. Acta Med Scand (1984) 0.82